In addition, expression of CSPG4 is not restricted to melanoma, but was also detected in various other cancer entities (17), and transfer of anti-CSPG4 CAR T cells controlled tumor growth in models of breast cancer, head and neck cancer, glioblastoma and sarcoma (17–19). This evidence concerns the gene CSPG4 and sarcoma.